chr16-30525580-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_024671.4(ZNF768):āc.560A>Gā(p.Asn187Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000457 in 1,614,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_024671.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF768 | NM_024671.4 | c.560A>G | p.Asn187Ser | missense_variant | 2/2 | ENST00000380412.7 | NP_078947.3 | |
ZNF768 | XM_017023665.3 | c.632A>G | p.Asn211Ser | missense_variant | 2/2 | XP_016879154.1 | ||
ZNF768 | XM_017023666.2 | c.467A>G | p.Asn156Ser | missense_variant | 2/2 | XP_016879155.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF768 | ENST00000380412.7 | c.560A>G | p.Asn187Ser | missense_variant | 2/2 | 1 | NM_024671.4 | ENSP00000369777 | P2 | |
ZNF768 | ENST00000562803.1 | c.467A>G | p.Asn156Ser | missense_variant | 2/2 | 3 | ENSP00000456527 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152232Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000338 AC: 85AN: 251460Hom.: 0 AF XY: 0.000324 AC XY: 44AN XY: 135902
GnomAD4 exome AF: 0.000475 AC: 695AN: 1461886Hom.: 0 Cov.: 67 AF XY: 0.000419 AC XY: 305AN XY: 727244
GnomAD4 genome AF: 0.000276 AC: 42AN: 152350Hom.: 0 Cov.: 34 AF XY: 0.000201 AC XY: 15AN XY: 74500
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at